Agilent Technologies Inc
NYSE:A

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
NYSE:A
Watchlist
Price: 136.1 USD 1.11% Market Closed
Market Cap: 39.1B USD
Have any thoughts about
Agilent Technologies Inc?
Write Note

Agilent Technologies Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Agilent Technologies Inc
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Agilent Technologies Inc
NYSE:A
PP&E Net
$2B
CAGR 3-Years
20%
CAGR 5-Years
18%
CAGR 10-Years
12%
Thermo Fisher Scientific Inc
NYSE:TMO
PP&E Net
$9.4B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
PP&E Net
$6B
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
11%
West Pharmaceutical Services Inc
NYSE:WST
PP&E Net
$1.7B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
9%
Mettler-Toledo International Inc
NYSE:MTD
PP&E Net
$790.4m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
4%
IQVIA Holdings Inc
NYSE:IQV
PP&E Net
$772m
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
15%
No Stocks Found

Agilent Technologies Inc
Glance View

Market Cap
38.8B USD
Industry
Life Sciences Tools & Services
Economic Moat
Narrow

Agilent Technologies Inc., a spin-off from Hewlett-Packard in 1999, has cultivated a niche in the vibrant landscape of the life sciences, diagnostics, and applied chemical markets. This California-based company, born from the legacy of one of Silicon Valley’s pioneers, has carved out its identity by providing sophisticated analytical instrumentation, software, services, and consumables for a wide range of applications. Agilent's businesses are stitched together by an underlying technology expertise, which forms the bedrock for its product lines that serve an increasing demand for precise and reliable analytical measurements. From cutting-edge liquid chromatography to mass spectrometry and genetic analysis systems, Agilent's offerings are geared towards supporting research and quality control processes across various industries, including pharmaceuticals, food safety, and environmental testing. The company's commitment to innovation and quality has consistently positioned it as a trusted partner in advancing the capabilities of laboratories worldwide. Agilent's revenue generation hinges on a strategic blend of product sales and services. The core of its business model revolves around not just selling instruments, but also establishing long-term relationships through service agreements, maintenance, and training. This recurring service revenue complements the sale of consumables and parts required for the operation of their sophisticated instruments. Additionally, Agilent has strategically expanded its footprint in the diagnostics market, providing instruments and reagents used in pathology laboratories, further diversifying its income streams. With a deliberate focus on high-growth areas, including genomics and cancer diagnostics, Agilent continues to leverage its technological prowess and industry expertise to capture market share in sectors that are inherently driven by the necessity for innovation and regulatory compliance. Through an intricate balance of hardware sales and consistent after-sale support, Agilent steadily maintains its role as a formidable player in the analytical instrumentation sector.

A Intrinsic Value
116.13 USD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Agilent Technologies Inc's PP&E Net?
PP&E Net
2B USD

Based on the financial report for Oct 31, 2024, Agilent Technologies Inc's PP&E Net amounts to 2B USD.

What is Agilent Technologies Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
12%

Over the last year, the PP&E Net growth was 37%. The average annual PP&E Net growth rates for Agilent Technologies Inc have been 20% over the past three years , 18% over the past five years , and 12% over the past ten years .

Back to Top